Mona S. El‐Zoghbi

500 citations

21 papers · 414 · h-index 12

Impact in

Organic Chemistry top 10%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Click Chemistry and Applications
- Synthesis and Characterization of Heterocyclic Compounds
- Quinazolinone synthesis and applications
Toxicology top 10%

Papers in

Organic Chemistry 15
- Synthesis and biological activity 10
- Synthesis and Biological Evaluation 7
- Synthesis and Characterization of Heterocyclic Compounds 5
- Quinazolinone synthesis and applications 4
Molecular Biology 11
- Cancer therapeutics and mechanisms 5
- Protein Degradation and Inhibitors 4
- Histone Deacetylase Inhibitors Research 4

Co-authors: Mohamed Badr (4 shared papers)Mamdouh F. A. Mohamed (4 shared papers)Gamal El‐Din A. Abuo‐Rahma (4 shared papers)Hamada S. Abulkhair (4 shared papers)Adel Ghiaty (3 shared papers)Ashraf H. Bayoumi (3 shared papers)Ebtehal M. Husseiny (2 shared papers)Hany E. A. Ahmed (2 shared papers)
Journals: Bioorganic Chemistry (3 papers)Journal of Enzyme Inhibition and Medicinal Chemistry (2 papers)European Journal of Medicinal Chemistry (2 papers)Future Medicinal Chemistry (2 papers)Molecular Diversity (1 paper)
Partner nations: Egypt Saudi Arabia Indonesia

In The Last Decade

Mona S. El‐Zoghbi

21 papers receiving 409 citations

Peers

Countries citing papers authored by Mona S. El‐Zoghbi

Since Specialization

Citations

This map shows the geographic impact of Mona S. El‐Zoghbi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona S. El‐Zoghbi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona S. El‐Zoghbi more than expected).

Fields of papers citing papers by Mona S. El‐Zoghbi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona S. El‐Zoghbi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona S. El‐Zoghbi. The network helps show where Mona S. El‐Zoghbi may publish in the future.

Co-authors

The 25 scholars most cited alongside Mona S. El‐Zoghbi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mona S. El‐Zoghbi Line = papers co-authored together Mona S. El‐Zoghbi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors European Journal of Medicinal Chemistry ·Amr K. A. Bass, Mona S. El‐Zoghbi, El-Shimaa M. Nageeb, Mamdouh F. A. Mohamed, Mohamed Badr, Gamal El‐Din A. Abuo‐Rahma	2020	89
2	From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity Bioorganic & Medicinal Chemistry ·Mohamed H. El‐Shershaby, Adel Ghiaty, Ashraf H. Bayoumi, Ahmed A. Al‐Karmalawy, Ebtehal M. Husseiny, Mona S. El‐Zoghbi, Hamada S. Abulkhair	2021	66
3	1,2,4-Triazolo[4,3-c]quinazolines: a bioisosterism-guided approach towards the development of novel PCAF inhibitors with potential anticancer activity New Journal of Chemistry ·Mohamed H. El‐Shershaby, Adel Ghiaty, Ashraf H. Bayoumi, Hany E. A. Ahmed, Mona S. El‐Zoghbi, Khaled El‐Adl, Hamada S. Abulkhair	2021	43
4	In vivo‐ and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors Archiv der Pharmazie ·Hamada S. Abulkhair, Salwa Elmeligie, Adel Ghiaty, Ahmed El-morsy, Ashraf H. Bayoumi, Hany E. A. Ahmed, Khaled El‐Adl, Mohamed F. Zayed, Memy H. Hassan, Eman N. Akl, Mona S. El‐Zoghbi	2021	40
5	Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase/HDAC inhibitors Bioorganic Chemistry ·Amr K. A. Bass, El-Shimaa M. Nageeb, Mona S. El‐Zoghbi, Mamdouh F. A. Mohamed, Mohamed Badr, Gamal El‐Din A. Abuo‐Rahma	2021	27
6	Potential antiviral and anticancer effect of imidazoles and bridgehead imidazoles generated by HPV-Induced cervical carcinomas via reactivating the P53/ pRb pathway and inhibition of CA IX Journal of Molecular Structure ·Aisha Y. Hassan, Samiha A. El‐Sebaey, Moshira A. El Deeb, Mona S. El‐Zoghbi	2021	22
7	Synthesis of certain benzothieno[3,2-d]pyrimidine derivatives as a selective SIRT2 inhibitors European Journal of Medicinal Chemistry ·Nadia A. Khalil, Eman Ahmed, Ashraf F. Zaher, Mona S. El‐Zoghbi, Eman A. Sobh	2019	18
8	Utility of 2-Methyl-quinazolin-4(3H)-one in the Synthesis of Heterocyclic Compounds with Anticancer Activity Aisha Youssif Hassan Helali, Marwa T. Sarg, Makarem Mohamed Said Koraa, Mona S. El‐Zoghbi	2014	17
9	New Pyrimidine-5-Carbonitriles as COX-2 Inhibitors: Design, Synthesis, Anticancer Screening, Molecular Docking, and In Silico ADME Profile Studies Molecules ·Hanan Al-Ghulikah, Samiha A. El‐Sebaey, Amr K. A. Bass, Mona S. El‐Zoghbi	2022	16
10	3-Cyano-2-oxa-pyridines: a promising template for diverse pharmacological activities DOAJ (DOAJ: Directory of Open Access Journals) ·Amr K. A. Bass, Elshimaa M. N. Abdelhafez, Mona S. El‐Zoghbi, Mamdouh F. A. Mohamed, Mohamed Badr, Gamal El‐Din A. Abuo‐Rahma	2021	16
11	Design, synthesis, docking, and anticancer evaluations of new thiazolo[3,2- a ] pyrimidines as topoisomerase II inhibitors Journal of Enzyme Inhibition and Medicinal Chemistry ·Mona S. El‐Zoghbi, Samiha A. El‐Sebaey, Hanan Al-Ghulikah, Eman A. Sobh	2023	15
12	Aminopyridone-Linked Benzimidazoles: A Fragment-Based Drug Design for the Development of CDK9 Inhibitors Future Medicinal Chemistry ·Ebtehal M. Husseiny, Hamada S. Abulkhair, Sanadelaslam SA El-Hddad, Nada Osama, Mona S. El‐Zoghbi	2023	11
13	New benzothienopyran and benzothienopyranopyrimidine derivatives as topoisomerase I inhibitors: Design, synthesis, anticancer screening, apoptosis induction and molecular modeling studies Bioorganic Chemistry ·Nadia A. Khalil, Eman Ahmed, Ashraf F. Zaher, Shimaa M. Alhamaky, Nada Osama, Mona S. El‐Zoghbi	2023	7
14	Synthesis, molecular modeling and biological evaluation of new benzo[4,5]thieno[3,2-b]pyran derivatives as topoisomerase I-DNA binary complex poisons Bioorganic Chemistry ·Eman Ahmed, Nadia A. Khalil, Ashraf F. Zaher, Shimaa M. Alhamaky, Mona S. El‐Zoghbi	2021	6
15	Novel thioxoimidazolidinone derivatives as dual EGFR and CDK2 inhibitors: Design, synthesis, anticancer evaluation with in silico study Journal of Molecular Structure ·Aisha Y. Hassan, Moshira A. El Deeb, Mona S. El‐Zoghbi, Samiha A. El‐Sebaey, Nada M. Mohamed	2023	6
16	Novel Aminopyrimidine-2,4-diones, 2-Thiopyrimidine-4-ones, and 6-Arylpteridines as Dual-Target Inhibitors of BRD4/PLK1: Design, Synthesis, Cytotoxicity, and Computational Studies Pharmaceuticals ·Samar El‐Kalyoubi, Samiha A. El‐Sebaey, Sherin M. Elfeky, Hanan Al-Ghulikah, Mona S. El‐Zoghbi	2023	4
17	Synthesis and Anticancer Activity Study of Some Novel Substituted and Fused Pyridotriazepine Derivatives Journal of Heterocyclic Chemistry ·Moshira A. El Deeb, Mona S. El‐Zoghbi	2018	3
18	Design, Synthesis and Mechanistic Study of New Dual Targeting HDAC/Tubulin Inhibitors Future Medicinal Chemistry ·Mona S. El‐Zoghbi, Amr K. A. Bass, Gamal El‐Din A. Abuo‐Rahma, Mamdouh F. A. Mohamed, Mohamed Badr, Hanan Al-Ghulikah, Elshimaa M. N. Abdelhafez	2024	3
19	New benzothieno[2,3-c]pyridines as non-steroidal CYP17 inhibitors: design, synthesis, anticancer screening, apoptosis induction, and in silico ADME profile studies Journal of Enzyme Inhibition and Medicinal Chemistry ·Nadia A. Khalil, Eman Ahmed, Ashraf F. Zaher, Eman A. Sobh, Samiha A. El‐Sebaey, Mona S. El‐Zoghbi	2021	2
20	Utility of activated nitriles in the synthesis of some new pyridine and fused pyridine derivatives with anticancer activity. DOAJ (DOAJ: Directory of Open Access Journals) ·Aisha Helali, Marwa T. Sarg, Mona S. El‐Zoghbi	2020	2

About Mona S. El‐Zoghbi

Mona S. El‐Zoghbi is a scholar working on Organic Chemistry, Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Toxicology, having authored 21 papers that have together received 414 indexed citations. Recurring topics across this work include Synthesis and biological activity (10 papers), Synthesis and Biological Evaluation (7 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers), Cancer therapeutics and mechanisms (5 papers), Cancer Mechanisms and Therapy (5 papers), Protein Degradation and Inhibitors (4 papers), Quinazolinone synthesis and applications (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Organic Chemistry (275 citations), Toxicology (27 citations), Geriatrics and Gerontology (11 citations), Molecular Biology (193 citations) and Computational Theory and Mathematics (40 citations). Mona S. El‐Zoghbi has collaborated with scholars based in Egypt, Saudi Arabia and Indonesia. Frequent co-authors include Mohamed Badr, Mamdouh F. A. Mohamed, Gamal El‐Din A. Abuo‐Rahma, Hamada S. Abulkhair, Adel Ghiaty, Ashraf H. Bayoumi, Ebtehal M. Husseiny, Hany E. A. Ahmed, Khaled El‐Adl and Ahmed A. Al‐Karmalawy. Their work appears in journals such as Bioorganic Chemistry, Journal of Enzyme Inhibition and Medicinal Chemistry, European Journal of Medicinal Chemistry, Future Medicinal Chemistry and Molecular Diversity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mona S. El‐Zoghbi

Impact in

Papers in i

In The Last Decade

Mona S. El‐Zoghbi

Peers

Countries citing papers authored by Mona S. El‐Zoghbi

Fields of papers citing papers by Mona S. El‐Zoghbi

All Works

About Mona S. El‐Zoghbi

Explore authors with similar magnitude of impact

Papers in